Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Inventory: 2015-2025

Historic Inventory for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Sep 2025 value amounting to $25.0 million.

  • Syndax Pharmaceuticals' Inventory was N/A to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $366,000 for FY2024, which is N/A change from last year.
  • Syndax Pharmaceuticals' Inventory amounted to $25.0 million in Q3 2025, which was up 41.27% from $17.7 million recorded in Q2 2025.
  • Syndax Pharmaceuticals' Inventory's 5-year high stood at $25.0 million during Q3 2025, with a 5-year trough of $22,000 in Q2 2021.
  • Moreover, its 2-year median value for Inventory was $11.2 million (2025), whereas its average is $11.9 million.
  • Data for Syndax Pharmaceuticals' Inventory shows a maximum YoY plummeted of 85.03% (in 2021) over the last 5 years.
  • Syndax Pharmaceuticals' Inventory (Quarterly) stood at $22,000 in 2021, then followed by $366,000 in 2024, then followed by $25.0 million in 2025.
  • Its Inventory stands at $25.0 million for Q3 2025, versus $17.7 million for Q2 2025 and $4.7 million for Q1 2025.